Dorval, QC, Feb. 12, 2018 – Today, Novartis Canada launches ExtraordinaryMoments.ca, a new online resource to raise awareness for, and provide support to women living with metastatic breast cancer (mBC) as well as their caregivers and family members.
Novartis is one of the leading pharmaceutical companies in oncology globally. For more than 20 years, Novartis Oncology has been focused on developing innovative treatments and support programs for people living with breast cancer, neuroendocrine tumours, and various forms of blood cancer. To further support patients and their families, Novartis has created ExtraordinaryMoments.ca.
“Novartis Oncology is committed to the innovation and improvement of cancer treatments and ensuring that people living with cancer, their caregivers and families are aware of the support available to them.” Winselow Tucker, General Manager, Novartis Oncology Canada. “Programs like Extraordinary Moments provide an opportunity to share experiences and educate Canadians about the unique needs of those living with, and affected by an advanced form of breast cancer.”
About Extraordinary Moments
ExtraordinaryMoments.ca is a site that includes a list of psychosocial support resources available for women living with mBC, their caregivers and family members. It also includes a short film that celebrates an everyday extraordinary moment, several engaging videos of women living with mBC and family members sharing their own extraordinary moments, and a video from prominent breast cancer associations in Canada including the Canadian Breast Cancer Network, the Quebec Breast Cancer Foundation and Rethink Breast Cancer.
About Novartis Pharmaceuticals Canada Inc.
Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. In 2016, the company invested $48.8 million in research and development in Canada. Located in Dorval, Quebec, Novartis Pharmaceuticals Canada Inc. employs approximately 750 people in Canada and is an affiliate of Novartis AG, which provides innovative healthcare solutions that address the evolving needs of patients and societies. For further information, please consult www.novartis.ca.